Tag: inspection findings

Governance Committees for High-Risk and Cross-Functional CAPAs In clinical research, effective governance is fundamental for maintaining compliance with Good Clinical Practice (GCP) guidelines, particularly when addressing Corrective and Preventive Actions (CAPAs). High-risk and cross-functional CAPAs, which often arise from complex regulatory findings or clinical trial discrepancies, require a structured approach to governance to ensure proper…

Read More “Governance Committees for High-Risk and Cross-Functional CAPAs” »

Preparing CAPA Narratives and Evidence Packages for Re-Inspections Corrective and Preventive Actions (CAPA) are integral to clinical trial management. They provide a systematic approach to addressing findings from regulatory inspections or audits in accordance with Good Clinical Practice (GCP). This in-depth tutorial will guide clinical operations, regulatory affairs, and medical affairs professionals through the process…

Read More “Preparing CAPA Narratives and Evidence Packages for Re-Inspections” »

Case Studies: CAPAs That Satisfied Regulators vs CAPAs That Failed Case Studies: CAPAs That Satisfied Regulators vs CAPAs That Failed Corrective and Preventive Actions (CAPAs) play a crucial role in ensuring compliance within clinical trial frameworks. They are essential not only for meeting regulatory expectations but also for improving overall clinical research quality. This article…

Read More “Case Studies: CAPAs That Satisfied Regulators vs CAPAs That Failed” »

Using CAPA Metrics to Drive a Culture of Continuous GCP Improvement Using CAPA Metrics to Drive a Culture of Continuous GCP Improvement In the field of clinical trials, adherence to Good Clinical Practice (GCP) is paramount to ensuring the integrity of data and the safety of participants. The integration of Corrective and Preventive Action (CAPA)…

Read More “Using CAPA Metrics to Drive a Culture of Continuous GCP Improvement” »

Digital CAPA Tools and Workflows for Global Clinical Organizations Digital CAPA Tools and Workflows for Global Clinical Organizations The integration of Corrective and Preventive Actions (CAPA) into clinical trial processes is critical for maintaining Good Clinical Practice (GCP) compliance. It ensures that clinical research organizations can address non-compliance and improve study quality effectively. This tutorial…

Read More “Digital CAPA Tools and Workflows for Global Clinical Organizations” »

Regulatory Expectations for CAPA Documentation and Follow-Through Regulatory Expectations for CAPA Documentation and Follow-Through In the context of pharmaceutical clinical trials, the integration of Corrective and Preventive Actions (CAPA) with Good Clinical Practice (GCP) findings is essential for ensuring compliance and overcoming regulatory scrutiny. This article outlines the step-by-step expectations regarding CAPA documentation and follow-through,…

Read More “Regulatory Expectations for CAPA Documentation and Follow-Through” »

Tracking CAPA Timelines, Ownership and Impact in GCP Programs In the fast-evolving landscape of clinical research, the integration of Corrective and Preventive Actions (CAPA) within Good Clinical Practice (GCP) programs has gained critical importance. The robustness of CAPA mechanisms can significantly influence the success of clinical trials, especially in environments governed by stringent regulations such…

Read More “Tracking CAPA Timelines, Ownership and Impact in GCP Programs” »

CAPA Read-Across: Applying Lessons From One Study to Many Introduction to CAPA and GCP in Clinical Trials Corrective and Preventive Actions (CAPA) play a crucial role in Clinical Research Operations, particularly in ensuring compliance with Good Clinical Practice (GCP). The purpose of CAPA is to address issues identified during clinical trials, fostering a proactive approach…

Read More “CAPA Read-Across: Applying Lessons From One Study to Many” »

Portfolio-Level CAPAs: When Single Findings Signal Systemic Issues Portfolio-Level CAPAs: When Single Findings Signal Systemic Issues In the highly regulated environment of pharma clinical trials, ensuring compliance with Good Clinical Practice (GCP) is paramount. One fundamental aspect of this compliance involves the identification and management of Corrective and Preventive Actions (CAPAs). This guide focuses on…

Read More “Portfolio-Level CAPAs: When Single Findings Signal Systemic Issues” »

Integrating CAPA Management Across QA, Operations and Functional Teams Integrating CAPA Management Across QA, Operations and Functional Teams The successful execution of clinical trials hinges on robust quality management systems that can effectively address deviations, non-conformities, and systemic failures. This document serves as a comprehensive tutorial for clinical research professionals looking to integrate Corrective and…

Read More “Integrating CAPA Management Across QA, Operations and Functional Teams” »